Impact of proton pump inhibitors on the effectiveness of clopidogrel after coronary stent placement: the clopidogrel Medco outcomes study.
about
Pharmacodynamic impacts of proton pump inhibitors on the efficacy of clopidogrel in vivo--a systematic reviewClopidogrel and proton pump inhibitors--where do we stand in 2012?Pharmacogenetics and anaesthesia: the value of genetic profilingBig data: the next frontier for innovation in therapeutics and healthcareLiterature based drug interaction prediction with clinical assessment using electronic medical records: novel myopathy associated drug interactionsImpact of proton pump inhibitor therapy on the efficacy of clopidogrel in the CAPRIE and CREDO trials.Clopidogrel: the data, the experience, and the controversies.Effect of clopidogrel on the hydroxylation and sulfoxidation of omeprazole: A single dose study in healthy human volunteers.Antiplatelet drug interactions with proton pump inhibitorsIncidence of cardiovascular events and gastrointestinal bleeding in patients receiving clopidogrel with and without proton pump inhibitors: an updated meta-analysisAddressing phenoconversion: the Achilles' heel of personalized medicine.Clinical evidence of interaction between clopidogrel and proton pump inhibitorsComparative risk of ischemic stroke among users of clopidogrel together with individual proton pump inhibitors.Enantiomers of naringenin as pleiotropic, stereoselective inhibitors of cytochrome P450 isoforms.Critical appraisal of ticagrelor in the management of acute coronary syndromeEffect of the clopidogrel-proton pump inhibitor drug interaction on adverse cardiovascular events in patients with acute coronary syndrome.Individual Proton Pump Inhibitors and Outcomes in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy: A Systematic ReviewClopidogrel and proton pump inhibitors: a clinically meaningful interaction?Clopidogrel pharmacogenetics: metabolism and drug interactions.The future of platelet function testing to guide therapy in clopidogrel low and enhanced responders.Update on selecting and adjusting antiplatelet therapy for prevention of noncardiogenic, recurrent ischemic stroke.Inconsistencies surrounding the risk of adverse outcomes with concomitant use of clopidogrel and proton pump inhibitors.The clinical relevance of the clopidogrel-proton pump inhibitor interaction.Proton pump inhibitors and clopidogrel: an association to avoid?East Asian perspective on the interaction between proton pump inhibitors and clopidogrel.Concomitant Use of Proton-Pump Inhibitors and Clopidogrel Increases the Risk of Adverse Outcomes in Patients With Ischemic Stroke Carrying Reduced-Function CYP2C19*2.Proton-Pump Inhibitor Use and the Risk of First-Time Ischemic Stroke in the General Population: A Nationwide Population-Based Study.Histamine-2 Receptor Antagonist Cannot Prevent Recurrent Peptic Ulcers in Patients With Atherosclerotic Diseases Who Receive Platelet ADP Receptor Antagonist Monotherapy: A Randomized-Controlled, Double-Blind, and Double-Dummy Trial.Clopidogrel and proton pump inhibitors: between a rock and a hard place.Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial.Differential inhibitory effects of proton pump inhibitors on the metabolism and antiplatelet activities of clopidogrel and prasugrel.A limited number of prescribed drugs account for the great majority of drug-drug interactions.New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment.Comparative Study of Effects of Vonoprazan and Esomeprazole on Antiplatelet Function of Clopidogrel or Prasugrel in Relation to CYP2C19 Genotype.Proton Pump Inhibitors in Cardiovascular Disease: Drug Interactions with Antiplatelet Drugs.
P2860
Q26822474-3705919F-71BB-40B8-9F51-40CBADB39E63Q26825728-CC16BA90-35CB-4298-B7F6-1ED10380E81AQ26859221-23503ED5-1782-4F75-97C5-0E7BA0C15351Q27027248-248CAE93-7A27-4BF9-8BC5-D785154307D3Q28482155-507A6384-C344-49A1-990C-B59AE0438782Q30421742-C8B38281-3E3B-4556-92CC-65081B778248Q30573045-93D13CEA-655B-4D0B-AEB6-8575E8CCAC48Q33667262-E75EBE00-1AB7-4ED9-8360-4A974C235779Q33948811-AFC907C7-44FC-4AFA-BB0C-099A94859EE2Q34486149-1FA8823C-1A95-4005-B951-17A023C030ABQ35023701-EACEF520-0116-4A79-BEB0-CD994D4D29BBQ35033722-B09CE3C2-5449-471A-90BF-8C6C4A40375BQ35126153-4FEEBE65-9274-4F44-B83E-F2856068972CQ35656097-6C2CF341-3448-47CA-BA06-253320D43BFEQ35660767-B839798C-1DB6-4F53-8686-AADE2C1309A2Q36493369-19C16FAD-1B0F-4D37-8285-B582BAACC1F3Q36836236-710DACB2-6D0D-4C0A-B9F6-59753D3F2829Q37831269-5AE1033D-21B8-44B1-9FBB-749AAA10B40CQ37912178-9EE77302-2B38-4EDA-9A6B-BD89182F631BQ37923969-8FC1E082-34AD-4F96-A672-1FF4B2334D80Q37943864-03F74A60-6241-403F-886E-05FC89F6E865Q37979853-FE3900FF-5384-495D-9360-09ED6388EAA6Q37986645-8F636ADB-4FA2-45AC-BB77-7E84EA884D0AQ38136990-5BD15E76-10EE-4359-BAC2-3ABB46AD1A40Q39055767-4CE0013F-CE67-4448-88E1-AD75ECEF8DDCQ39380363-40844317-4647-4D2D-8B79-E2BBB4FC9A37Q40248473-B4430383-1C61-488C-91A8-FE5238AD7C49Q40422122-C522F350-334D-4ED4-B84B-667A903D2B12Q42961054-D580EE9A-5104-4440-8A0F-7E1C1533F409Q43565621-9A1B3BD0-BA94-48E2-8595-4C348C565005Q43643259-5C0A4B83-577F-4D6A-8C99-BA5556267C7FQ44904056-A50A5A0E-3E0C-4F09-BBF1-BB7004EDF911Q45019665-04954A44-E12D-468F-8D7E-8EE7737B363BQ50217765-BC00DFDD-0BFA-4C27-987B-21BF35510D0FQ51507688-E1E21591-24B1-40F8-B0F6-AEBD90D55307
P2860
Impact of proton pump inhibitors on the effectiveness of clopidogrel after coronary stent placement: the clopidogrel Medco outcomes study.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Impact of proton pump inhibito ...... pidogrel Medco outcomes study.
@en
Impact of proton pump inhibito ...... pidogrel Medco outcomes study.
@nl
type
label
Impact of proton pump inhibito ...... pidogrel Medco outcomes study.
@en
Impact of proton pump inhibito ...... pidogrel Medco outcomes study.
@nl
prefLabel
Impact of proton pump inhibito ...... pidogrel Medco outcomes study.
@en
Impact of proton pump inhibito ...... pidogrel Medco outcomes study.
@nl
P2093
P2860
P356
P1433
P1476
Impact of proton pump inhibito ...... pidogrel Medco outcomes study.
@en
P2093
Eric J Stanek
Felix W Frueh
J Russell Teagarden
Jeffrey A Breall
Jianying Yao
Robert S Epstein
Rolf P Kreutz
Ronald Aubert
Todd C Skaar
P2860
P304
P356
10.1592/PHCO.30.8.787
P407
P577
2010-08-01T00:00:00Z